This article is more than 5 years old. Information may no longer be current.
OSN’s top news of the week
Click Here to Manage Email Alerts
Here are some of the recent top stories on Healio.com/OSN:
Xelpros gains FDA approval for open-angle glaucoma, ocular hypertension
Xelpros (latanoprost ophthalmic solution 0.005%) is the first latanoprost product not formulated with the preservative benzalkonium chloride and was developed with SPARC’s Swollen Micelle Microemulsion technology. Read more.
Risk score may help identify schoolchildren at high risk for myopia
A newly developed risk score that combines environmental and ocular factors may help identify schoolchildren who are at high risk for myopia. Read more.
ASCRS task force to investigate CyPass micro-stent study data
ASCRS Clinical Committee leaders who specialize in glaucoma and cornea will make up the task force, which will conduct an independent evaluation of the data. Read more.
Adverum Biotechnologies receives fast track designation for wet AMD therapy
The FDA granted fast track designation for ADVM-022, a novel gene therapy candidate for the treatment of wet age-related macular degeneration. Read more.
PACK-CXL yields ‘ good response ’ in antibiotic-resistant infectious keratitis
PACK-CXL proved effective as a treatment for infectious keratitis in a series of patients with large, central corneal ulcers not responding to antimicrobial treatment. Read more.